Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier

被引:44
|
作者
Li, Mu-xia [1 ]
Li, Min-yao [1 ]
Lei, Jun-xuan [1 ]
Wu, Yu-zhu [1 ]
Li, Ze-hao [1 ]
Chen, Lin-ming [2 ]
Zhou, Chang-lin [3 ]
Su, Ji-yan [4 ]
Huang, Guo-xin [5 ]
Huang, Xiao-qi [1 ]
Zheng, Xue-bao [1 ]
机构
[1] Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China
[2] Guangzhou Huibiao Testing Technol Ctr, Guangzhou 510700, Peoples R China
[3] Dongguan Peoples Hosp, Dongguan 523000, Peoples R China
[4] Southern Med Univ, Affiliated Foshan Matern & Child Healthcare Hosp, Foshan 528000, Guangdong, Peoples R China
[5] Shantou Cent Hosp, Clin Res Ctr, Shantou 515041, Peoples R China
关键词
Huangqin decoction; Ulcerative colitis; Gut microbiota; Amino acid metabolism; mTOR pathway; Intestinal epithelial barrier;
D O I
10.1016/j.phymed.2022.154052
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: The clinical treatment of ulcerative colitis (UC) is limited. A traditional Chinese medicinal formula, Huangqin decoction (HQD), is chronicled in Shang Han Lun and is widely used to ameliorate gastrointestinal disorders, such as UC; however, its mechanism is yet to be clarified. Purpose: The present study aimed to investigate the effect of HQD on 7-day colitis induced by 3% dextran sulfate sodium (DSS) in mice and further explore the inhibitory effect of metabolites on DSS-damaged FHC cells. Methods: The therapeutic efficacy of HQD was evaluated in a well-established DSS-induced colitis mice model. The clinical symptoms were analyzed, and biological samples were collected for microscopic examination, metabolomics, metagenomics, and the evaluation of the epithelial barrier function. The mechanism of metabolites regulated by HQD was evaluated in the DSS-induced FHC cell damage model. The samples were collected to detect the physiological functions of the cells. Results: HQD suppressed the inflammation of DSS-induced colitis in vivo, attenuated DSS-induced clinical manifestations, reversed colon length reduction, and reduced histological injury. After HQD treatment, the DSSinduced gut dysbiosis was modulated, and the gut microbiota achieved a new equilibrium state. In addition, HQD activated the mTOR signaling pathway by upregulating amino acid metabolism. Significant phosphorylation of S6 and 4E-BP1 ameliorated intestinal epithelial barrier dysfunction. Moreover, HQD-regulated metabolites protected the epithelial barrier integrity by inhibiting DSS-induced apoptosis of FHC cells and regulating the proteins affecting apoptosis and cell-cell junction. Conclusions: These findings indicated that the mechanism of HQD was related to regulating the gut microbiota and amino acid metabolism, activating the mTOR signaling pathway, and protecting the intestinal mucosal barrier integrity.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Fermented Glutinous Rice Extract Mitigates DSS-Induced Ulcerative Colitis by Alleviating Intestinal Barrier Function and Improving Gut Microbiota and Inflammation
    Kim, Kwang-Youn
    Son, Jae Dong
    Hwang, Su-Jin
    Lee, Jong Kwang
    Park, Jae Young
    Park, Kwang Il
    Oh, Tae Woo
    ANTIOXIDANTS, 2023, 12 (02)
  • [32] Selenium-containing tea polysaccharides ameliorate DSS-induced ulcerative colitis via enhancing the intestinal barrier and regulating the gut microbiota
    Zhao, Yuning
    Chen, Hong
    Li, Wenting
    He, Qian
    Liang, Jingyimei
    Yan, Xiaohai
    Yuan, Yahong
    Yue, Tianli
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 209 : 356 - 366
  • [33] Metformin protects against mucus barrier dysfunction via gut microbiota in DSS-induced ulcerative colitis in mice
    Ke, Haoran
    Li, Fang
    Deng, Wenlin
    Li, Zitong
    Chen, Ye
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 187 - 187
  • [34] Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response
    Wang, Yongfu
    Liu, Jingjing
    Huang, Ziwei
    Li, Yucui
    Liang, Yuanyuan
    Luo, Chaodan
    Ni, Chen
    Xie, Jianhui
    Su, Ziren
    Chen, Jiannan
    Li, Cailan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 896
  • [35] Huangkui Lianchang Decoction Ameliorates DSS-Induced Ulcerative Colitis in Mice by Inhibiting the NF-kappaB Signaling Pathway
    He, Zongqi
    Zhou, Qing
    Wen, Ke
    Wu, Bensheng
    Sun, Xueliang
    Wang, Xiaopeng
    Chen, Yugen
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [36] Shikimic Acid Regulates the NF-κB/MAPK Signaling Pathway and Gut Microbiota to Ameliorate DSS-Induced Ulcerative Colitis
    Li, Xin
    Mo, Kaibin
    Tian, Ge
    Zhou, Jiaxin
    Gong, Jiongzhou
    Li, Li
    Huang, Xianhui
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (23) : 8906 - 8914
  • [37] Sijunzi decoction alleviates inflammation and intestinal epithelial barrier damage and modulates the gut microbiota in ulcerative colitis mice
    Li, Hailun
    Pu, Xing
    Lin, Yongtao
    Yu, Xinxin
    Li, Jing
    Bo, Lin
    Wang, Hongwu
    Xu, Yong
    Li, Xiang
    Zheng, Donghui
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [38] Chitin protects the gut epithelial barrier in a protochordate model of DSS-induced colitis
    Liberti, Assunta
    Zucchetti, Ivana
    Melillo, Daniela
    Skapura, Diana
    Shibata, Yoshimi
    De Santis, Rosaria
    Pinto, Maria Rosaria
    Litman, Gary W.
    Dishaw, Larry J.
    BIOLOGY OPEN, 2018, 7 (01):
  • [39] The Protective Role of TLR4 in Intestinal Epithelial Cells through the Regulation of the Gut Microbiota in DSS-Induced Colitis in Mice
    Shi, Yun-Jie
    Huang, Cheng
    Gong, Pi-Qing
    Liu, Cong
    Hu, Zhi-Qian
    Wang, Hao
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (08):
  • [40] Resolvin D1 ameliorates hepatic steatosis by remodeling the gut microbiota and restoring the intestinal barrier integrity in DSS-induced chronic colitis
    Zeng, Cui
    Liu, Xinghuang
    Zhu, Siran
    Xiong, Danping
    Zhu, Liangru
    Hou, Xiaohua
    Zou, Kaifang
    Bai, Tao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 103